New patent expiration for APGDI drug MYRBETRIQ

Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…

Source


Comments are closed.

Biotechblog